Synthesis, structure-activity relationships and biological evaluation of 7-phenyl-pyrroloquinolinone 3-amide derivatives as potent antimitotic agents. 2017

Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131, Padova, Italy.

A small library of 7-pyrrolo[3,2-f]quinolinones was obtained by introducing benzoyl, sulfonyl and carbamoyl side chains at the 3-N position, and their cytotoxicity against a panel of leukemic and solid tumor cell lines was evaluated. Most of them showed high antiproliferative activity with GI50s ranging from micro-to sub-nanomolar values, and these values correlated well with the inhibitory activities of the compounds against tubulin polymerization. Based on a recently proposed colchicine bind site inhibitors (CBSIs) pharmacophore, the interactions of the novel 7-PPyQs at the colchicine domain were rationalized. The most active compounds (4a and 4b) did not induce significant cell death in normal human lymphocytes, suggesting that the compounds may be selective against cancer cells. In particular, 4a was a potent inducer of apoptosis in both the HeLa and Jurkat cell lines. On the other hand, the sulfonyl derivative 4b exhibited a lower potency in comparison with 4a. With both compounds, induction of apoptosis was associated with dissipation of the mitochondrial transmembrane potential and production of reactive oxygen species, suggesting that cells treated with the compounds followed the intrinsic pathway of apoptosis.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000577 Amides Organic compounds containing the -CO-NH2 radical. Amides are derived from acids by replacement of -OH by -NH2 or from ammonia by the replacement of H by an acyl group. (From Grant & Hackh's Chemical Dictionary, 5th ed) Amide
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin

Related Publications

Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
January 2005, Bioorganic & medicinal chemistry,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
May 2004, Journal of medicinal chemistry,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
July 2015, Bioorganic & medicinal chemistry,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
August 2002, Bioorganic & medicinal chemistry letters,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
August 2009, Yao xue xue bao = Acta pharmaceutica Sinica,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
February 2009, Bioorganic & medicinal chemistry,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
June 2008, Journal of medicinal chemistry,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
March 2011, European journal of medicinal chemistry,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
October 2006, ChemMedChem,
Davide Carta, and Roberta Bortolozzi, and Mattia Sturlese, and Veronica Salmaso, and Ernest Hamel, and Giuseppe Basso, and Laura Calderan, and Luigi Quintieri, and Stefano Moro, and Giampietro Viola, and Maria Grazia Ferlin
April 2022, Bioorganic chemistry,
Copied contents to your clipboard!